| 000 | 02724nam a22005415i 4500 | ||
|---|---|---|---|
| 001 | 978-3-7643-7407-5 | ||
| 003 | DE-He213 | ||
| 005 | 20161121230709.0 | ||
| 007 | cr nn 008mamaa | ||
| 008 | 100301s2006 sz | s |||| 0|eng d | ||
| 020 |
_a9783764374075 _9978-3-7643-7407-5 |
||
| 024 | 7 |
_a10.1007/3-7643-7407-1 _2doi |
|
| 050 | 4 | _aRC254-282 | |
| 072 | 7 |
_aMJCL _2bicssc |
|
| 072 | 7 |
_aMED062000 _2bisacsh |
|
| 082 | 0 | 4 |
_a616.994 _223 |
| 245 | 1 | 0 |
_aDrugs Affecting Growth of Tumours _h[electronic resource] / _cedited by Herbert M. Pinedo, Carolien H. Smorenburg. |
| 264 | 1 |
_aBasel : _bBirkhäuser Basel, _c2006. |
|
| 300 |
_aIX, 238 p. _bonline resource. |
||
| 336 |
_atext _btxt _2rdacontent |
||
| 337 |
_acomputer _bc _2rdamedia |
||
| 338 |
_aonline resource _bcr _2rdacarrier |
||
| 347 |
_atext file _bPDF _2rda |
||
| 490 | 1 | _aMilestones in Drug Therapy | |
| 505 | 0 | _aAntimetabolites -- DNA-intercalators — the anthracyclines -- Topoisomerase inhibitors -- Tubulin interacting agents -- Vaccination therapies in solid tumors -- Oral anticancer agents -- Anti-angiogenesis agents -- Signal transduction inhibitors -- Endocrine therapy of breast cancer. | |
| 520 | _aDuring recent years the field of effective anticancer agents has substantially increased. The use of chemotherapy has been accepted as a standard therapy for an expanding number of tumour types and stages, while many new agents are being investigated when standard therapy is lacking or failing. Apart from new targets for anticancer agents, attention is also focused on improving efficacy and tolerability of existing compounds. This topical volume provides an up-to-date overview of clinically relevant data on anticancer agents, and is not only intended for those working as a medical doctor with cancer patients, but also for medical researchers and students. The different classes of anticancer drugs are described by international authorities on the various topics. | ||
| 650 | 0 | _aMedicine. | |
| 650 | 0 | _aCancer research. | |
| 650 | 0 | _aImmunology. | |
| 650 | 0 | _aPharmacology. | |
| 650 | 0 | _aOncology. | |
| 650 | 0 | _aCell biology. | |
| 650 | 1 | 4 | _aMedicine & Public Health. |
| 650 | 2 | 4 | _aOncology. |
| 650 | 2 | 4 | _aPharmacology/Toxicology. |
| 650 | 2 | 4 | _aCancer Research. |
| 650 | 2 | 4 | _aImmunology. |
| 650 | 2 | 4 | _aCell Biology. |
| 700 | 1 |
_aPinedo, Herbert M. _eeditor. |
|
| 700 | 1 |
_aSmorenburg, Carolien H. _eeditor. |
|
| 710 | 2 | _aSpringerLink (Online service) | |
| 773 | 0 | _tSpringer eBooks | |
| 776 | 0 | 8 |
_iPrinted edition: _z9783764321963 |
| 830 | 0 | _aMilestones in Drug Therapy | |
| 856 | 4 | 0 | _uhttp://dx.doi.org/10.1007/3-7643-7407-1 |
| 912 | _aZDB-2-SBL | ||
| 950 | _aBiomedical and Life Sciences (Springer-11642) | ||
| 999 |
_c502626 _d502626 |
||